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Electronic health recordWe present the Unsupervised Phenome Model (UPhenome), a probabilistic graphical model for
large-scale discovery of computational models of disease, or phenotypes. We tackle this challenge
through the joint modeling of a large set of diseases and a large set of clinical observations. The
observations are drawn directly from heterogeneous patient record data (notes, laboratory tests,
medications, and diagnosis codes), and the diseases are modeled in an unsupervised fashion. We apply
UPhenome to two qualitatively different mixtures of patients and diseases: records of extremely sick
patients in the intensive care unit with constant monitoring, and records of outpatients regularly
followed by care providers over multiple years. We demonstrate that the UPhenome model can learn
from these different care settings, without any additional adaptation. Our experiments show that (i)
the learned phenotypes combine the heterogeneous data types more coherently than baseline
LDA-based phenotypes; (ii) they each represent single diseases rather than a mix of diseases more often
than the baseline ones; and (iii) when applied to unseen patient records, they are correlated with the
patients’ ground-truth disorders. Code for training, inference, and quantitative evaluation is made
available to the research community.
 2015 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Clinicians routinely document the care of their patients in elec-
tronic health records (EHRs). Throughout the years, patient records
accumulate medical history as myriad individual observations:
results of laboratory tests and diagnostic procedures; interven-
tions; medications; and detailed narratives about disease course,
treatment options, and family and social history. When caring for
an individual patient, clinicians reason in the context of the
patient’s medical history. This is a cognitively difficult task. First,
the search space for potential diseases that may account for the
patients’ symptoms is very large. Second, the individual clinical
observations that form the patient’s record are many, thus poten-
tially overwhelming in aggregate, and at the same time each of
them is potentially imperfect and uncertain.
Computational tools and techniques that reduce the dimension-
ality of the many individual patient characteristics, that discoverunderlying clinically meaningful latent states of the patient, and
that allow reasoning in a probabilistic fashion over them would
be powerful allies to clinicians. In fact, these tools would also facil-
itate many analytics tasks when applied to entire patient popula-
tions, including predicting disease progression, comparing
effectiveness of treatments, and studying disease interactions
[1–5]. For such tools to operate in a robust fashion across varied
patients and enable high-throughput search over many diseases,
modeling from large amounts of patient records is critical. How
to build these tools is an open research question.
Here, we tackle this challenge through jointly modeling a large
set of diseases and an even larger set of clinical observations. The
observations are drawn directly from the heterogeneous EHR data,
and the diseases are modeled in an unsupervised fashion. We refer
to this task as large-scale probabilistic phenotyping, in essence
building computational models of diseases from patient records.
We introduce the UPhenome model in its first iteration, a
graphical model for large scale probabilistic phenotyping. The
key contributions of the model are:
 It models diseases and patient characteristics as a mixture
model, thus scaling easily to large sets of diseases and clinical
observations.
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patient observations—from raw data and diverse data types
common to most EHRs: text, laboratory tests, medications,
and diagnosis codes.
 It is unsupervised, and as such, can learn disease models across
datasets from different institutions and different care settings,
such as intensive care, emergency care, and primary care.
 It leverages a topic modeling approach, handling issues inherent
to EHR data such as sparsity and noise, and capturing relations
among observations that are implicit in the records.
2. Related work
We discuss related work according to two areas of research:
computational models of disease and probabilistic graphical mod-
els in the clinical domain.
2.1. Computational models of disease
One of the promises of the EHR is to enable reasoning and deci-
sion support over patient record data. Therefore, deriving a compu-
tationally actionable representation of patients based on their
clinical records has been a grand research challenge, with proposed
solutions from several disciplines and research fields. Since health-
care is driven almost entirely by the presence and/or severity of
disease, representing diseases in an actionable fashion has been
much investigated over the years.
The eMERGE phenotyping effort aims to model individual dis-
eases one at a time. It relies heavily on expert consensus to build
disease definitions that can be applied over a large set of EHRs.
While time consuming, this effort yields precise phenotypes of sin-
gle diseases [6]. More recently, single disease modeling efforts
have focused on automated feature extraction from knowledge
sources to reduce the manual effort involved in creating precise
phenotypes [7]. In addition to single disease phenotyping,
researchers have also explored the use of clustering techniques
to identify subtypes of a given individual disease [8–11].
When it comes to modeling a very large set of diseases at once,
most of the work to date has been heavily reliant on manual
knowledge curation. Ontologies like SNOMED-CT [12] encode
information about diseases such as potential treatments, symp-
toms, and the relationships among them. Bayesian networks which
encode relationships among diseases and symptoms have also
been developed [13]. The Internist 1/QMR-DT resource was created
manually and allows for computational reasoning about diseases
and symptoms [14,15]. One drawback of these resources is that,
while their content is curated, they do not necessarily link to
observation types documented in patient records.
Approaches that leverage healthcare data—whether claims data
or EHR data—to represent diseases and their interactions have also
been proposed in the literature [16–18]. However, these
approaches focus on interactions among diseases rather than mod-
eling the diseases themselves.
Recently, a novel method to learn representations of multiple
diseases across a large set of patients was proposed based on
matrix factorization [19]. In this framework, unseen patients can
be assigned phenotypes, as defined by a collection of diagnosis
codes.
Our work aims for a similar goal to that of Ho and colleagues
[19]: the UPhenome model learns phenotypes for a wide range of
diseases, and derives the model based on EHR data. However, the
UPhenome model departs from previous work in disease modeling
in the following ways: it learns a representation jointly over
heterogeneous EHR data types, and it operates in a probabilistic
framework, thus enabling modeling of the uncertainty inherent
in noisy EHR observations.2.2. Probabilistic graphical models in the clinical domain
With the growing amount of EHR data in electronic format,
modeling the EHR with latent variable models has been an increas-
ingly active area of research. The well-established Latent Dirichlet
Allocation (LDA) model [20] has been applied to raw clinical text
for several tasks, such as identifying sets of similar patients [21],
correlating disease topics with genetic mutations [22], and predict-
ing ICU mortality [23] with success, suggesting that topic modeling
can act as a powerful and reliable dimensionality reduction tech-
nique. Such unsupervised modeling of topics is attractive as the
language of clinical notes is particularly noisy with much para-
phrasing power, and styles (e.g., abbreviations) that vary widely
from one institution to another and from one care setting to the
next. Most recently, researchers applied LDA to billing codes from
disparate EHRs and found sets of phenotypes that remain consis-
tent across multiple institutions, further demonstrating the power
and portability of unsupervised learning techniques[24]. Research-
ers have also investigated novel probabilistic graphical models,
also used in a variety of tasks, including ICU illness severity scoring
[25], diagnosis code prediction [26], redundancy-aware topic mod-
eling [27], disease progression modeling [28], and disease subtypes
identification [11].
While some clinical latent variable models have been evaluated
in task-based settings (e.g., [23]), evaluating the intrinsic value of
the learned latent variables beyond their face validity, as well as
their ability to infer meaningful latent states on unseen data can
yield much information about the models. For general domain
texts, evaluation methods of topic modeling have been much
investigated. Experiments to obtain human judgments have been
proposed [29], and automatic metrics that aim to correlate with
such judgments (i.e., held-out likelihood and automatic topic
coherence) have been explored [30–32]. Reliable and valid human
judgments of topics are difficult to obtain, and as such automatic
metrics are attractive. In the clinical domain, these metrics have
not been validated fully, and quality judgments from clinicians
are critical. When it comes to our phenotyping task, we want to
evaluate how well the latent variables represent individual dis-
eases. Because clinicians are trained to think about diseases as
probabilistic mixture of symptoms, treatments, and comorbidities,
we can leverage this training towards collecting qualitative judge-
ments of phenotypes.
Our goal in developing the UPhenome model is to build inter-
pretable disease models that are clinically valid and actionable.
As such, we developed the model with knowledge of the EHR char-
acteristics in mind and designed experiments to test for clinical
relevance of the learned phenotypes.
3. The UPhenome Model
The UPhenome model proposed in this paper is a mixed mem-
bership model, inspired by the topic model literature [20,33]. This
model learns computational representations of disease based on
observations from patient records, as encoded in the EHR. The cur-
rent version of the model is fully unsupervised.
3.1. Inputs and Outputs
The input to UPhenome consists of a large set of patient records,
where each record is composed of free-text notes, medication
orders, diagnosis codes, and laboratory tests. Each data type is trea-
ted as a bag of elements. The words in the notes are tokenized and
simple filtering of vocabulary is based on token frequency as well
as stop words removal. The medication orders are mapped when-
ever possible to bag of medication classes. The diagnosis codes are
also encoded as a bag of codes.
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types and an inference mechanism to identify a specific phenotype
distribution for an unseen patient record. The learned phenotypes
can act as computational models of disease, and can be evaluated
according to their interpretability and clinical relevance. In addi-
tion, the top-ranked diagnosis for a given phenotype can be used
as a label proxy, thus supporting the interpretability of the disease
model.
The inference mechanism acts as a dimension reduction tech-
nique, where each new patient record can now be represented as
a distribution over a concise set of clinically meaningful variables
(the learned phenotypes). Such a representation can be leveraged
in many health analytics tasks, including patient record summa-
rization, risk prediction, and patient cohort selection. The variables
of the model are listed in Table 1.3.2. Baseline Models
Before describing the UPhenome model, we first describe two
baseline models. The first baseline, LDA-text, considers only the
notes in the records, following the hypothesis that clinical informa-
tion about the diseases of a patient will be documented in the
notes and thus can be captured through standard topic modeling.
This is a state-of-the-art approach in several models for clinical
data [21,23]. Our first baseline is thus a vanilla LDA applied to
the bag of words in the notes. We ran preliminary experiments
with LDA on only diagnosis codes (similar to the method used by
Chen et al. [24]) but chose to focus the discussion on LDA-text
given our task of large-scale disease modeling and the abundance
of words in the patient records.
The second baseline, LDA-all, learns topic models based on all
observations in the record (words, medications, diagnosis codes,
and laboratory tests). In this baseline we apply a vanilla LDA on
all observation types in a single bag. The working hypothesis for
this baseline is that diseases can be represented across the differ-
ent data types in the record. This baseline model has the exact
same input as the UPhenome model.3.3. Graphical Model
In the UPhenome model, a patient record is represented as a
probabilistic mixture of phenotypes, and the phenotypes are
defined as a mixture of characteristics derived from a large, diverseTable 1
Variables in the UPhenome model.
P Number of phenotypes
R Number of patient records
br Phenotype distribution for patient record r
gp Diagnosis code distribution for phenotype p
Ir Number of diagnosis codes in record r
v i;r Diagnosis code instance i in record r
ci;r Phenotype assignment for diagnosis code i in record r
hp Words distribution for phenotype p
Nr Number of words in record r
wn;r Word instance n in record r
dn;r Phenotype assignment for word n in record r
ip Medications distribution for phenotype p
Or Number of medication orders in record r
xo;r Medication instance o in record r
o;r Phenotype assignment for medication o in record r
jp Laboratory test distribution for phenotype p
Mr Number of laboratory tests in record r
ym;r Laboratory test instance m in record r
fm;r Phenotype assignment for test m in record rpopulation of patients. A phenotype is defined as a set of distribu-
tions over the observation vocabularies, one for each of the four
heterogeneous data types. As in the LDA baselines, we model the
observations and phenotype assignments as multinomial distribu-
tions, and the phenotype distributions as sets of Dirichlet distribu-
tions. The details of the probabilistic latent variable model are
shown in Fig. 1 and Algorithm 1. For completeness, Ir; Nr ; Or ; Mr ,
etc. are assumed to be Poisson distributed but in practice this does
not influence inference as these are fixed quantities.
Algorithm 1. Generative story for the UPhenome model.
The UPhenome model departs from the LDA-text baseline by
considering all data types in the record. It departs from the LDA-
all baseline by treating each data type on its own, and learning
the type-specific phenotype distribution separately (gp, hp, ip, jp
variables). There are multiple advantages to treating the data types
this way: (i) this formulation adheres to the genre and characteris-
tic of EHRs; (ii) it allows for future specification of different levels
of sparsity and distributions for each data types; (iii) it enables a
platform for incorporating domain knowledge specific to each data
type; and (iv) it enforces the principle that conditioned on pheno-
type assignments, the per-data phenotype distributions are inde-
pendent of each other. Since the four phenotype distributions
must separately sum to one, this mitigates potential imbalance inFig. 1. Graphical representation of the UPhenome model.
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type (e.g., words) from overwhelming the less frequent ones (e.g.,
diagnosis codes).3.4. Inference
To perform inference on the UPhenome model, we derived a
collapsed Gibbs sampler which collapses the parameters b, g, h, i,
j. Due to the similarity of the models, inference in the UPhenome
model follows methods previously outlined for inference in LDA
[33]. For illustrative purposes, we show the conditional distribu-
tion necessary for Gibbs sampling for one of the phenotype assign-
ment variables, the laboratory test phenotype assignment, and
note that the conditionals for the other phenotype assignment
variables follow closely.
pðfm;r ¼ pjfðm;rÞ; . . .Þ /
pþPRr¼1Mðm;rÞr;p;l
 
P jj j
l¼1 pl þ
PR
r¼1M
ðm;rÞ
r;p;l
 
 aþ Ir;p þ Nr;p þ Or;p þMðm;rÞr;p;l
 
:
Here, the notation Ir;p represents the total count of all diagnosis
code tokens Ir in patient record r, that are assigned to phenotype p.
Similarly for Nr;p (word tokens) and Or;p (medications).
The counts for laboratory tests are performed without counting
the particular laboratory test instance, m, which belongs to the
type l and for which the conditional distribution is being evalu-
ated. Therefore, Mðm;rÞr;p;l represents the total count of all laboratory
tests, Mr , in patient record r, that are assigned to phenotype p,
except (represented by a minus) for the current laboratory test
instance m in record r.
Finally, we note that the denominator of this conditional only
contains counts for the laboratory test, demonstrating the differ-
ences across the phenotype distributions for each data type.
4. Experimental setup
We now describe our datasets, parameter settings and model
selection, as well as the different evaluation experiments we
carried out. Code is available at http://www.github.com/rimmap/
Phenome_Model.
4.1. Datasets
To investigate the generalizability of the UPhenome model, we
experimented with two qualitatively different mixtures of patients
and patient diseases: (1) records of extremely sick patients who
are in the intensive care unit (ICU) with constant monitoring,
which usually spans a few days; and (2) records for outpatients
regularly followed by care providers over multiple years. These
datasets are also from different institutions using different EHRTable 2
Descriptive statistics for the MIMIC and NYPH training datasets. In this work, the
number of patients and the number of input records is equivalent. Each MIMIC
patient has one input record consisting of all data gathered during one ICU stay and
each NYPH patient has one input record consisting of all data gathered during four
consecutive outpatient visits.
Data type MIMIC total/unique NYPH total/unique
Patients 18,697/18,697 9828/9828
Words 13,086,278/12,919 13,494,149/13,158
Medications 1,044,541/855 9978/273
Lab tests 7,499,446/309 351,992/300
Diagnoses 159,740/985 177,420/931systems. In each dataset, 80% of the records were used for training,
and 20% for testing. Descriptive statistics about the training sets for
each dataset are given in Table 2.
MIMIC II ICUDataset. TheMIMIC IIClinicalDatabase (v2.26) [34] is
available at http://physionet.org/mimic2_clinical_overview.shtml.
MIMIC II contains a de-identified set of over 23,000 adults from
the Beth Israel Deaconess Medical Center’s Intensive Care Units,
including medical, surgical, and coronary care units. The dataset
contains structured record data, and unstructured clinical note data.
Patients have abroad set of existing conditions and reasons for being
in the ICU. As this dataset is available to researchers who sign a data
usage agreement, anywork on this dataset can serve as a benchmark
for future automated phenotyping algorithms.
We included all adult patients in the dataset, independently of
their present or absent conditions. For each record, we selected one
ICU admission and all of its corresponding observations: discharge
summary, all medications, all diagnosis codes, and all laboratory
tests. Medications and laboratory tests were mapped to the stan-
dard vocabulary definitions provided by MIMIC. For all data types,
we limited the vocabulary to observations that appeared at least 20
times across the entire training dataset.
NewYork-Presbyterian Hospital Outpatient Dataset. The
NewYork-Presbyterian Hospital (NYPH) outpatient dataset con-
tains longitudinal records of patients with at least three outpatient
visits (e.g., specialist or primary care provider). Their records
include all their visits, however, ranging from outpatient visits to
hospital admissions, to emergency department visits. Like the
MIMIC patients, the NYPH patients have a broad set of conditions,
but unlike them their records span years instead of days, and the
documented conditions differ as well.
We included all patients, independently of their conditions.
Since their records span decades and often hundreds of visits, we
considered slices of records for each patient that capture a some-
what stable health status (thus again, making for a qualitatively
different dataset than the MIMIC patients). We selected the most
recent time slice of each record, that contained four different pri-
mary provider notes with no intervening inpatient stays. We
defined record lengths by number of notes and not absolute time
to account for different rates of visit. Any patient whose record
slice lasted less than 1 month or greater than 4 years was removed
and this resulted in patient records with mean length of 10 months
(7 months standard deviation).
Like in MIMIC, we collected all observations related to primary
provider notes, medications, diagnosis codes, and laboratory tests.
The range of medications is much more diverse than MIMIC med-
ications, and thus we mapped all medications to their therapeutic
class when possible (e.g., ‘‘Tylenol” was mapped to ‘‘Analgesic”).
Similarly, the laboratory tests were mapped to groups of tests
when possible (e.g., ‘‘Glucose fingerstick” was mapped to ‘‘Glu-
cose”). Thus, the vocabulary sizes for these observations was dra-
matically reduced. We applied frequency thresholds to the data
to closely match MIMIC vocabulary sizes whenever possible.
IRB approval was obtained from the Columbia University Med-
ical Center Institutional Review Board. As part of the approved IRB
protocol, an application for waiver of authorization was filled and
approved, as we investigate algorithms for learning statistical
models across a very large population and historical data across
many years, and thus obtaining individual consent would be
impracticable.
4.2. Model parameters and model selection
We ran UPhenome using 50, 75, 100, 250, 500, 750 phenotypes.
All of the hyperparameters (a, l, m, n, p) were set to 0.1 for all mod-
els. To ensure appropriate burn-in time for each model, the Gibbs
sampler was run 7000 iterations and the log-likelihood curves on
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type assignment settings for each model were selected as the ones
that produced the maximum log-likelihood over all 7000 iterations
on the training set.
For model selection, we optimized for interpretability of pheno-
types, and thus relied on both held-out likelihood and coherence of
the learned phenotypes. The automated phenotype coherence
calculation was performed using normalized pointwise mutual
information (NPMI) over all observation types, as described by
Lau et al. [32] and using the provided open source code. For each
model, we used the average NPMI across all phenotypes to repre-
sent the overall coherence of the learned phenotypes from the
model.
For this experiment, NPMI is calculated for each observation (zi)
in each phenotype, limited to the top 40 (N = 40) most probable
observations. The per-phenotype NPMI is the average of the NPMI
of each observation that is associated with that phenotype. The
model NPMI is the average of each per-phenotype NPMI value
and is defined by
NPMIðziÞ ¼ 
XN1
j¼1
log Pðzi ;zjÞPðziÞPðzjÞ
log Pðzi; zjÞ ;
where P(zi) = probability of seeing observation zi and P(zi; zj) = prob-
ability of seeing both observation zi and observation zj in the same
patient record.
To calculate the likelihood on the held-out set, we implemented
a Chib-style estimator as described by Murray and Salakhutdinov
[35]. The likelihood was calculated using 1000 iterations of the
estimator for every setting of P.
The combination of the two metrics suggested that P = 250 was
likely to produce the best phenotypes given the current parameter
settings on the MIMIC dataset. We report results on the NYPH
dataset that are also obtained with P = 250 as well.
For both baseline models LDA-text and LDA-all, we used the
MALLET software package[36] with similar number of topics as
the selected UPhenome model (K = 250) and similarly with 7000
iterations to ensure burn-in. The hyperparameter settings for the
baseline models were 0.01 to increase sparsity due to the larger
size of the combined vocabulary.
4.3. Evaluation experiments
In addition to the automated evaluation metrics, such as held-
out likelihood and automatic coherence of the learned phenotypes,
we carried out the following set of experiments: qualitative assess-
ment of learned phenotypes (manual coherence, manual granular-
ity, pairwise phenotype comparison, label quality) and ability of
the phenotypes to characterize ground-truth disorders present in
a set of unseen patients (disorders to phenotypes associations).
All qualitative judgments were obtained from a clinical expert.
The learned phenotypes were displayed using a modified version of
the interactive topic modeling interface [37]. The interface is par-
ticularly useful to us because it enables users to edit learned phe-
notypes by adding/removing observations and marking them asFig. 2. An example of learned phenotype from the NYPH dataset. The top-40 most proba
green, medications are gray, and diagnosis codes are blue.important or ignorable. For each phenotype, the top 40 most prob-
able observations were displayed and weighted by their phenotype
probability (normalized by their data-type specific phenotype
probability). The observations were also color-coded to signify
their data types (purple for words, gray for medications, green
for laboratory tests, and blue for diagnosis codes). See Fig. 2 for
an example of displayed topic.
Manual coherence. This experiment allows us to capture the
intrinsic quality of the learned phenotypes across its probable
observations, very much like the automatic coherence metric aims
to. In our case, a coherent phenotype is one that describes a single
condition and that does not contain observations that are not typ-
ically seen in patients with this condition.
For the UPhenome model and the baseline LDA-all model each,
50 phenotypes were randomly selected and presented one at a
time to the clinical expert. The expert was asked to score the
coherence of a given phenotype (without being told whether it
was produced by the LDA-all or UPhenome) according to a 1–5 Lik-
ert scale, where 1 designated no coherence (i.e., a junk phenotype)
and 5, perfect coherence. To help the expert in his assessment, we
instructed him to use the interface to edit the phenotypes, and use
his number of edits as a cue for lack of coherence.
Manual granularity. Because both the baseline and the UPhe-
nome models are unsupervised, there is no guarantee that the
learned phenotypes are good representations of clinically mean-
ingful diseases. In particular, it is possible that the modeling of
patient observations generates clusters that are reflective of the
documentation processes of healthcare rather than of the docu-
mentation of clinical status of a patient. For instance, patient dis-
charge to a nursing home in the MIMIC dataset contains very
specific documentation patterns, which in an unsupervised setting
could be easily grouped.
We asked the clinical expert to categorize the 100 random phe-
notypes (50 from the UPhenome model and 50 from the LDA-all
baseline) into one of the following three granularities: (i) a non-
disease phenotype (e.g., a documentation phenotype, or a junk
phenotype); (ii) a mix of diseases; and (iii) a single disease.
Pairwise phenotype comparison. In this experiment, we assess
the compared overall quality between the learned UPhenome phe-
notypes and learned LDA-baselines phenotypes. To ensure that the
comparison is fair, we selected the 50 random UPhenome pheno-
types, and identified the most similar corresponding LDA-all phe-
notype for each. To compute pairwise phenotype similarity, we
used Jensen-Shannon divergence over the posterior probabilities
of all observations [38]. The clinical expert was presented pairs
of phenotypes (a UPhenome and a paired LDA-baselines pheno-
type) without him knowing which model generated which pheno-
type. The expert was asked to choose which phenotype was more
clinically coherent or to code the comparison as impossible when
both phenotypes were junk, equivalent, or paired improperly.
Label quality. One of the data types used in the UPhenome
model is diagnosis codes. The diagnosis codes are ICD-9 codes,
which often describe specific diseases (e.g., ‘‘breast cancer”), but
can also describe classes of diseases (e.g., ‘‘malignant neoplasms”),
as well as generic statements about a patient (e.g., ‘‘personalble observations for the phenotype are listed. Words are purple, laboratory tests are
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in the clinical world as proxies for conditions present in a patient,
this experiment assesses to which extent the most probable diag-
nosis code for a learned phenotype is a clinically appropriate label
for the phenotype as a whole.
Since the LDA-text baseline does not include diagnosis codes, so
this experiment was skipped for this model. Similarly, since in the
baseline LDA-all model it is possible that the top-40 most probable
observations do not include any diagnosis code (in our experiment,
this happened actually very often), we assessed label quality for
the 50 UPhenome phenotypes only.
We asked the clinical expert to categorize the top diagnosis
code with respect to the phenotype as a whole as (i) related; (ii)
unrelated; or (iii) actionable. An actionable label is one that accu-
rately represents the phenotype at the right granularity and it can
be relied upon when making a decision about a patient with the
phenotype assigned.
Disorders to phenotypes associations. While the previous experi-
ments assessed the quality of the learned phenotypes, this experi-
ment assesses the ability of the UPhenome phenotypes to
characterize clinically relevant and ground-truth disorders present
in a set of unseen patient records. If there is a strong association
between phenotypes and the disorders in these records, then the
phenotypes can be considered clinically relevant for a given
patient.
A potential application of the UPhenome model to identify pre-
sent disorders for a given patient by inferring the most probable
phenotypes for the record. To validate this point, we relied on a
gold-standard set of records, which contain manual annotations
of the disorders present and mentioned in the records’ notes. The
ShARe gold standard is based on MIMIC notes and contains such
annotations [39,40]. We included the 350 discharge summaries
from the ShARe corpus in our test set. For each record, gold-
standard annotation provided a list of SNOMED-CT Disorder con-
cepts, along with modifiers such as negation and uncertainty
[12,41]. Ground-truth disorders for a record were defined as con-
cepts with no negation or uncertainty.
In total, for each of the 350 records, we have ground-truth dis-
order concepts (from a set of 2000+ unique concepts in the corpus)
and inferred phenotype assignments. We created an association
matrix, similar to [33], visualizing the degree of association
between present concepts and phenotypes. We selected the con-
cepts which occurred in at least 50 records. This experiment exam-
ines associations between common disorders and learned
phenotypes; with 350 patients, there are not enough annotations
to associate phenotypes with rare disorders. The association was
computed using normalized pointwise mutual information, and
for each concept the top phenotype was selected.Fig. 3. Distribution of manual coherence scores for the UPhenome and LDA-all
phenotypes. A score of 1 represents a junk phenotype and 5, a perfect phenotype.5. Results
Fig. 2 shows an example of learned phenotype on the NYPH
dataset. The label on the left is the most probable diagnosis code,
in this case SLE (Systematic Lupus Erythematosus). The words (in
purple) are indeed related to this disease and refer to abbreviations
in clinical notes (‘‘rheum”) or mentions of important laboratory
tests for SLE (‘‘ana”, ‘‘esr”), as well as mentions of specific drugs
indicated for SLE (‘‘plaquenil”). The medications are also related
(plaquenil, one of the most common drug for SLE is an antimalarial
medication), as well as prednisone. Both C3 and C4 levels are used
as diagnosis tests for SLE, while ESR and others test for level of
inflammation in a patient. SLE is a phenotype learned from the
NYPH dataset, which represents outpatient records over long peri-
ods of time. Since SLE is a chronic disease it makes sense that it was
discovered in this dataset. For comparison, there is no phenotypelearned on the MIMIC dataset that captures characteristics of SLE.
Because the UPhenome model is unsupervised, it models the dis-
eases that are of interest to a given input clinical setting/patient
cohort.
For the remainder of the paper, we present results of our exper-
iments on the publicly available MIMIC dataset. Furthermore, for
the comparison of the UPhenome model with baselines, we report
its comparison to the LDA-all baseline alone, but note that the
results were similar as for the comparison to the LDA-text baseline.
Manual coherence. Fig. 3 shows the distribution of coherence
scores for the 50 phenotypes from the UPhenome model and the
50 phenotypes from the LDA-all model. The LDA-all phenotypes
contained many more junk phenotypes than the UPhenome ones,
and at the same time contained slightly more perfectly coherent
phenotypes than the UPhenome ones. Overall, about 66% of the
UPhenome phenotypes were scored as good (coherence score
above 4), while only about 52% of the LDA-all phenotypes were
scored as good.
Manual granularity. The UPhenome model yielded more pheno-
types that are clinically well-defined as representing a single dis-
ease than the LDA-all baseline. Furthermore, the LDA-all baseline
suffered from a high number of junk phenotypes (as confirmed
by the Manual coherence experiment).
For the UPhenome phenotypes, the clinical expert categorized
10% as non-disease phenotypes, 10% as a mix of diseases, and
80% as representing a single disease. In contrast, for the LDA-all
phenotypes, the clinical expert categorized 42% as non-disease
phenotypes, 6% as a mix of diseases, and 52% as representing a sin-
gle disease.
Pairwise phenotype comparison. Fig. 4 displays an example of
paired phenotypes shown to the clinical expert. We can see that
the most probable observations in the LDA-all phenotype are
words and laboratory tests (except for one medication), with only
a few highly probable and relevant words/tests and most irrelevant
to iron deficiency anemia. In comparison, the most probable obser-
vations in the UPhenome phenotype are spread across data types,
with a majority of observations relevant to iron deficiency anemia.
Overall, out of the 50 pairs of phenotypes assessed, the clinical
expert considered comparison impossible for 9 pairs. The UPhe-
nome phenotype was superior to the LDA-all one in 80.4% of the
remaining pairs.
Label quality. Overall, the most probable diagnosis code for a
given phenotype was evaluated as promising proxy for a pheno-
type label. The clinical expert assigned a label as actionable for
Fig. 4. An example of LDA-all and UPhenome phenotypes, both about Iron Deficiency Anemia, as paired automatically by Jensen Shannon divergence.
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related, while only 8% of them were considered unrelated.
Disorders to phenotypes associations. Fig. 5 shows the association
matrix between the present disorders in the gold standard ShARe
corpus and the inferred phenotypes on the gold-standard records.
There were 15 disorder concepts that were present for at least 50
patients in the dataset. As such the matrix is 15  15. For clarity
purposes, we grouped the 15 disorder concepts based on each
other’s clinical similarities. For instance, hypertension, hyperc-
holesterolemia, and type II diabetes are often seen together in
patients, and similarly for the symptoms nausea and vomiting.
The figure indicates there is an association between the com-
mon disorders present in the gold-standard records and their
inferred phenotypes. Upon inspection of the inferred phenotypes,
they are good representations of the present disorders. For
instance, Phenotype 7 has the highest association with the disorder
Mitral Valve Regurgitation, and its most probable observations are
perfectly coherent with respect to this disease.
When concepts shared clinical characteristics (e.g., nausea and
vomiting or the cluster of hypertension, diabetes, and hypercholes-
terolemia), the associated phenotypes are also shared among them
(e.g., phenotypes 12,13 and phenotypes 1,2).
We display two more examples of phenotypes. Phenotype 10,
which is associated with hemorrhage shows several diagnosis
codes, all potentially leading or describing hemorrhages. Pheno-
type 11 is a junk topic, containing highly prevalent observations
throughout the MIMIC dataset.
6. Discussion
The results of the various automated and manual evaluations
suggest that the UPhenome model is a promising approach to dis-
cover models of disease. We discuss next two characteristics of our
model—the joint modeling of heterogeneous data types and their
unsupervised modeling—as well as the differences between
automated and manual coherence assessments for the task of
phenotyping.Joint modeling of heterogeneous EHR data. The UPhenome model
is designed to leverage the innate heterogeneity of EHR data. By
modeling each data type separately as opposed to a bag of observa-
tions like in the LDA-all baseline, the model can accommodate for
imbalance of observations from each data type. For instance, there
are many more words than diagnosis codes, even after stop words
removal and vocabulary filtering. By design, the UPhenome model
ensures that each data type is represented in the learned pheno-
types, thus truly modeling across data types. This explains for
instance, why all UPhenome phenotypes given as examples in
the paper have a mix of data types, while most LDA-all phenotypes
are overwhelmed by words and laboratory tests (i.e., the most
common data types in our observations, as described in Table 2).
Generative unsupervised modeling of EHR data. Like all unsuper-
vised models, UPhenome is exciting in its ability to discover pat-
terns in input datasets, such as disease models. When applied to
the MIMIC corpus, the learned phenotypes are representative of
diseases that are documented in an intensive care unit, like acute
kidney failure, while when applied to the NYPH dataset, the
learned phenotypes are more representative of chronic and acute
conditions that do not require intensive care, such as SLE.
Without careful modeling however, unsupervised models can
yield unwanted results. The LDA-all phenotypes often highlighted
information about hospital course in aspects nonspecific to any
underlying condition, such as coagulation status, palliative care
status, type of drug exposure, and plan for discharge. All of these
topics make sense and represent distinct patterns in the input
datasets, but they do not represent diseases. In contrast, the UPhe-
nome phenotypes represented a greater number of distinct disease
than the LDA-all phenotypes. Furthermore, they were more clini-
cally relevant, as multiple aspects of a given disease were included
such as secondary complications or potential treatments.
In this version of the model, we did not explore the use of dif-
ferent distributions, maybe more adapted to our task. For instance,
several learned phenotypes corresponded to highly prevalent dis-
eases (i.e., these diseases had several phenotypes representing
them). Potential fixes for this phenomenon include tuning the
Fig. 5. Association of manually identified ground-truth concepts and automatically inferred phenotypes over a set of patients, along with four example phenotypes.
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data-type specific phenotype distributions.
Automated coherence metrics vs. human judgments. When com-
paring the average coherence of the LDA-all phenotypes and the
UPhenome phenotypes, LDA-all yielded a significantly higher aver-
age Normalized Pointwise Mutual Information (NPMI) (.07 vs
.014).
NPMI was established as a valuable automated evaluation met-
ric of learned topics and was shown to correlate with human judg-
ments of topic coherence[32]. In our experiments however, we
found little correlation between the clinician’s judgments and the
NPMI of the learned phenotypes (Pearson R = 0.31 and Spear-
man = 0.33 over 50 UPhenome phenotypes). In our settings, the
UPhenome model is a mixture model over text but also coded data
(e.g., diagnosis codes, medications, and laboratory results). It is
possible that the computationally coherent (often co-occurring
terms) are not actually clinically relevant. For instance, theLDA-all phenotype with the highest NPMI contained the following
most probable observations: ‘‘pm total co pt potassium gap sodium
urea chloride anion glucose creat hct hgb rbc mcv mchc mch wbc
rdw”, a mix of routine, non-discriminatory laboratory tests. It is
also possible that different observations within coded data types
may not occur frequently together. For instance, there are several
diagnosis codes which are highly clinically relevant with each
other, and yet do not get coded together in patient records: differ-
ent stages of pancreatic cancer for example, would make sense in a
single phenotype for the disease, but will not be seen jointly over
many patients at a time.
7. Conclusion and future work
Building computational models of disease has been an active
area of research, with approaches ranging from building ontologies
and taxonomies of diseases based on clinical expertise, to creating
164 R. Pivovarov et al. / Journal of Biomedical Informatics 58 (2015) 156–165highly precise model of specific diseases of interest through a mix
of data-driven and clinical expertise, to discovering models directly
from clinical observations. The UPhenome model is an unsuper-
vised, generative model, which given a large set of EHR observa-
tions, learns probabilistic phenotypes. The phenotypes are
learned jointly over heterogeneous EHR observations drawn from
a large set of potential medications, diagnosis codes, laboratory
tests, and free-text clinical notes. When applied to specific patient
records, the UPhenome model can provide actionable representa-
tion of the records, by describing them as a distribution over the
patient’s inferred phenotypes.
We demonstrate that the UPhenome model can learn from dif-
ferent care settings and documentations of different healthcare
institutions, without any adaptation needed. Our experiments
show that the UPhenome model yields phenotypes that (i) com-
bine all these data types in a coherent fashion better than baseline
models; (ii) are representative of single diseases, while baseline
models tended to produce representations of either mixes of dis-
ease or high-level healthcare process; and (iii) when applied to
unseen patient records, are correlated with the patients’ ground-
truth disorders.
The code for the UPhenome model is available at http://www.
github.com/rimmap/Phenome_Model. Furthermore, the MIMIC
dataset is available to the research community.
This paper presents the first iteration of the UPhenome model,
which as such makes several simplification assumptions about
the data and the task. We describe next our future work to address
these current limitations.
Future Work. We plan our future work along the following direc-
tions: (i) temporality of EHR data and diseases; (ii) better modeling
of the different data types; and (iii) grounding of the learned phe-
notypes with clinical knowledge about disease.
In its current version, the UPhenome model does not explicitly
encode any temporality about given patient records. Because lon-
gitudinal records and diseases themselves are often not time
invariant [43], and progress at different time resolutions, it is a
non-trivial task to model temporality across all diseases at once.
A simple baseline experiment toward incorporating temporality
is to infer phenotypes over time, much like the approach of
dynamic topic models [44].
Each of the considered data types in the UPhenome model have
specific characteristics that can be exploited further. The EHR text,
especially when learning from several notes for each patient, has
much redundancy that can be accounted for [27]. Medications
and diagnosis codes are hierarchical in nature, with evidence that
incorporating that structure helps in modeling clinical information
[26]. Finally each laboratory test has associated values, and it is
clear that different distributions of the same test can describe dif-
ferent diseases; for instance, glucose with a distribution biased
towards high values would belong to a phenotype describing dia-
betes, while glucose with a distribution with mean towards low
values would be probable in a hypoglycemia phenotype. Better
modeling of the data types based on the genre of EHR datasets is
an attractive and promising avenue of research.
In addition to incorporating knowledge about EHR characteris-
tics, we are eager to investigate the use of clinical knowledge in
improving probabilistic phenotyping. A primary goal of our work
is to generate phenotypes compatible with clinician’s mental mod-
els of diseases. Incorporating a human in the loop, like in interac-
tive topic modeling [37] and clinical anchor learning [45] is a
promising approach. Another approach to support this goal is to
incorporate knowledge from existing clinical knowledge resources,
inspired by the advances in constrained topic modeling [46,47,37],
and incorporating known semantic relations in disease modeling
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